Sequencing Consumables Market Report 2026

Sequencing Consumables Market Overview

• Sequencing Consumables market size has reached to $12.36 billion in 2025 • Expected to grow to $36.6 billion in 2030 at a compound annual growth rate (CAGR) of 23.6% • Growth Driver: Genetic Diseases Driving Growth In Sequencing Consumables Market • Market Trend: Innovative Solutions In The Sequencing Consumables Market • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Sequencing Consumables Market?

Sequencing consumables refer to the various reagents, kits, and materials used during the DNA or RNA sequencing. These consumables are essential for preparing, amplifying, and analyzing genetic samples in sequencing workflows. Sequencing consumables are designed to work with specific sequencing platforms and technologies, ensuring genomic data generation's accuracy, efficiency, and reliability. The main products of sequencing consumables are kits, reagents, and accessories. Sequencing kits are laboratory tools containing necessary reagents and protocols for DNA or RNA sequencing processes. The platform encompasses first-generation, second-generation, and third-generation sequencing consumables, utilized across applications such as cancer diagnostics, infectious disease diagnostics, reproductive health diagnostics, pharmacogenomics, agrigenomics, and others. These are employed by end-users including pharmaceutical and biotechnology companies, hospitals, laboratories, academic research institutes, and others.

What Is The Sequencing Consumables Market Growth Forecast?

The sequencing consumables market size is expected to see exponential growth in the next few years. It will grow to $36.6 billion in 2030 at a compound annual growth rate (CAGR) of 23.6%. The growth in the forecast period can be attributed to increasing demand for personalized medicine, expansion of infectious disease genomics, growing adoption of third-generation sequencing technologies, rising investments in genomic data analysis, increasing use of sequencing in population health studies. Major trends in the forecast period include increasing demand for high-throughput sequencing consumables, rising adoption of next-generation sequencing kits, growing use of specialized reagents for precision diagnostics, expansion of platform-specific consumable portfolios, enhanced focus on workflow efficiency and accuracy.

Global Sequencing Consumables Market Segmentation

1) By Product: Kits, Reagents, Accessories 2) By Platform: 1st Generation Sequencing Consumables, 2nd Generation Sequencing Consumables, 3rd Generation Sequencing Consumables 3) By Application: Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics, Others Application 4) By End-Use: Pharmaceutical And Biotechnology Companies, Hospitals And Laboratories, Academic Research Institutes, Other End-Uses Subsegments: 1) By Kits: Library Preparation Kits, DNA Or RNA Amplification Kits, Sequencing Kits 2) By Reagents: PCR Reagents, DNA Or RNA Reagents, Enzymes 3) By Accessories: Sequencing Chips, Primers And Probes, Sample Preparation Tools

What Is The Driver Of The Sequencing Consumables Market?

The rising prevalence of genetic diseases is expected to propel the growth of the sequencing consumables market going forward. Genetic diseases are disorders caused by abnormalities in an individual's DNA or genes, often inherited from their parents. The rising prevalence of genetic diseases is attributed to factors such as increased awareness, improved diagnostics, and changing environmental conditions. Sequencing consumables are utilized in genetic diseases for DNA extraction, library preparation, sequencing, and analysis to identify genetic variants associated with disease. For instance, in July 2025, according to the National Blood Authority, an Australia-based blood management agency, there were 2,788 patients living with hereditary haemophilia A (HMA) in 2023–2024, up from 2,681 patients in 2022–2023. Therefore, the rising prevalence of genetic diseases is driving the growth of the sequencing consumables industry.

Key Players In The Global Sequencing Consumables Market

Major companies operating in the sequencing consumables market are F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc, Merck KGaA, Becton Dickinson And Company, Agilent Technologies Inc, Illumina Inc, PerkinElmer Inc, Beckman Coulter Inc, Bio-Rad Laboratories Inc, QIAGEN N.V., Tecan Group AG, BGI Genomics Co Ltd, Promega Corporation, Abcam Limited, Integrated DNA Technologies Inc., Takara Bio Inc, Oxford Nanopore Technologies plc, Pacific Biosciences Of California Inc, Analytik Jena GmbH, Standard BioTools Inc, LGC Biosearch Technologies Inc., Apex Biotechnology Corp., Lexogen GmbH

Global Sequencing Consumables Market Trends and Insights

Major companies operating in the sequencing consumables market are focused on developing innovative solutions, such as human whole-genome sequencing (WGS) assays, to enhance accuracy, efficiency, and speed in genomic analysis. Human whole-genome sequencing (WGS) assays involve the comprehensive analysis of an individual's entire genome, including all of their DNA, to identify genetic variations, mutations, and biomarkers associated with health, disease risk, and treatment response. For instance, in March 2023, Illumina Inc., a US-based biotechnology company, launched Illumina Complete Long Read Prep- Human, a high-performance, long-read, human whole-genome sequencing (WGS) assay. The Illumina Complete Long Read Prep, Human is compatible with Illumina NovaSeq X Plus, NovaSeq X, and NovaSeq 6000 Sequencing Systems. It provides users access to long- and short-read data on a single Illumina instrument for the first time. This offering simplifies workflows and significantly reduces DNA input requirements compared to other long-read options.

What Are Latest Mergers And Acquisitions In The Sequencing Consumables Market?

In January 2023, QIAGEN N.V., a Germany-based biotechnology company, acquired Verogen for an undisclosed amount. Through this acquisition, QIAGEN seeks to strengthen its leadership in human identification and forensics by integrating next-generation sequencing (NGS) technologies for more effective investigations. Verogen is a US-based biotechnology company that specializes in DNA-based human identification and sequencing products and forensic genomic analysis.

Regional Outlook

North America was the largest region in the sequencing consumables market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Sequencing Consumables Market?

The sequencing consumables market consists of sales of reagents, kits, enzymes, buffers, and plates. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.